111 Total Current Liabilities 2018-2024 | YI

111 total current liabilities from 2018 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
111 Annual Total Current Liabilities
(Millions of US $)
2024 $321
2023 $387
2022 $395
2021 $334
2020 $250
2019 $111
2018 $46
2017 $30
111 Quarterly Total Current Liabilities
(Millions of US $)
2024-12-31 $321
2024-09-30 $378
2024-06-30 $341
2024-03-31 $358
2023-12-31 $387
2023-09-30 $409
2023-06-30 $320
2023-03-31 $364
2022-12-31 $395
2022-09-30 $317
2022-06-30 $336
2022-03-31 $328
2021-12-31 $334
2021-09-30 $316
2021-06-30 $321
2021-03-31 $267
2020-12-31 $250
2020-09-30 $261
2020-06-30 $175
2020-03-31 $129
2019-12-31 $111
2019-09-30 $93
2019-06-30 $96
2019-03-31 $69
2018-09-30 $52
2017-12-31 $30
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.071B $1.973B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.136B 58.95
Hims & Hers Health (HIMS) United States $12.000B 124.67
Tempus AI (TEM) United States $10.868B 0.00
IRhythm Technologies (IRTC) United States $4.592B 0.00
Inspire Medical Systems (INSP) United States $4.068B 63.55
Hinge Health (HNGE) United States $3.121B 0.00
Privia Health (PRVA) United States $2.805B 191.75
Enovis (ENOV) United States $1.818B 10.14
Schrodinger (SDGR) United States $1.741B 0.00
Clover Health Investments (CLOV) United States $1.567B 0.00
Phreesia (PHR) United States $1.501B 0.00
Omnicell (OMCL) United States $1.466B 25.86
Azenta (AZTA) United States $1.310B 60.89
10x Genomics (TXG) United States $1.150B 0.00
Fulgent Genetics (FLGT) United States $0.648B 0.00
Claritev (CTEV) United States $0.605B 0.00
Butterfly Network (BFLY) United States $0.591B 0.00
Talkspace (TALK) United States $0.553B 165.25
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.353B 784.00
Outset Medical (OM) United States $0.342B 0.00
Health Catalyst (HCAT) United States $0.275B 0.00
Nyxoah SA (NYXH) Belgium $0.263B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
KORU Medical Systems (KRMD) United States $0.130B 0.00
Pulmonx (LUNG) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.118B 0.00
American Well (AMWL) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.101B 0.00
CareCloud (CCLD) United States $0.091B 3.45
HeartBeam (BEAT) United States $0.057B 0.00
P3 Health Partners (PIII) United States $0.047B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00